The Analyst Landscape: 6 Takes On PROCEPT BioRobotics

分析师的视角：关于PROCEPt生物机器人六个看法

Benzinga · 2024/11/15 02:01

In the latest quarter, 6 analysts provided ratings for PROCEPT BioRobotics (NASDAQ:PRCT), showcasing a mix of bullish and bearish perspectives.

在最近一个季度中，6位分析师为Procept BioRobotics（纳斯达克股票代码：PRCT）提供了评级，显示了看涨和看跌的观点。

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。

In the assessment of 12-month price targets, analysts unveil insights for PROCEPT BioRobotics, presenting an average target of $93.83, a high estimate of $105.00, and a low estimate of $75.00. Observing a 17.58% increase, the current average has risen from the previous average price target of $79.80.

在评估12个月目标股价时，分析师公布了对Procept BioRobotics的见解，将平均目标价定为93.83美元，最高估计为105.00美元，低估值为75.00美元。目前的平均价格上涨了17.58％，已从之前的平均目标价79.80美元上涨。

Decoding Analyst Ratings: A Detailed Look

解码分析师评级：详细介绍

An in-depth analysis of recent analyst actions unveils how...

对分析师近期行为的深...

登录免费看全文

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

The Analyst Landscape: 6 Takes On PROCEPT BioRobotics

The Analyst Landscape: 6 Takes On PROCEPT BioRobotics

风险及免责提示

声明